Movement Disorders

Papers
(The H4-Index of Movement Disorders is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
In Memoriam Mahlon R. DeLong (1938–2024)460
John Michael Walshe (April 24, 1920–October 14, 2022)150
A Multi‐center Genome‐wide Association Study of Cervical Dystonia120
X‐Linked Dystonia‐Parkinsonism (“Lubag”) May Present with Peripheral Synucleinopathy118
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy106
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia105
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism95
Issue Information92
YY1: A New Gene for Childhood Onset Dystonia with Prominent Oromandibular‐Laryngeal Involvement?90
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials86
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 1284
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease84
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease81
Movement Disorders: Volume 40, Number 2, February 202580
Classifying Idiopathic Rapid Eye Movement Sleep Behavior Disorder, Controls, and Mild Parkinson's Disease Using Gait Parameters76
75
Is Persistent Motor or Vocal Tic Disorder a Milder Form of Tourette Syndrome?74
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy71
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure70
Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [18F]‐FEMPA PET Study69
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?69
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism68
Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating65
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model63
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia63
Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait62
Clinical Utility of 18F‐APN‐1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy62
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation61
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease59
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property58
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers58
Mortality of People with Parkinson's Disease in a Large UK‐Based Cohort Study: Time Trends and Relationship to Disease Duration57
Movement Disorders: Volume 36, Number 11, November 202156
Obituary for Jan O. Aasly (1950–2022)56
Movement Disorders: Volume 37, Number 9, September 202256
Author Index55
October Infographic54
54
Reply to: “Application of the mPSPRS to the Salerno Cohort”54
Effect of Public Interest in Magnetic Resonance Imaging–Guided Focused Ultrasound on Enrolment for Deep Brain Stimulation53
Reply to: “An Exponential Rather Than Multistep Model of Parkinson's Disease Pathogenesis”53
Reply to: “Adult‐Onset Neurodegeneration in Nucleotide Excision Repair Disorders: More Common than Expected”52
Issue Information51
Thank you to Reviewers 202250
Downbeat Nystagmus in Episodic Ataxia Type 1 Associated with a Novel KCNA1 Mutation49
Genetic Determinants of Survival in Parkinson's Disease in the Asian Population48
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2‐Hydroxypropyl‐β‐Cyclodextrin Treatment47
Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder47
0.085261821746826